Mesoblast lining up partners for stem cell trials – The Australian
The Australian Financial Review |
犀利士
NE2-Vpy2FzJxxNrgEUK5PWiwyDC1g&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52778871168986&ei=jaN2VfixDIXC3AHWioDQAQ&url=http://www.theaustralian.com.au/business/latest/mesoblast-lining-up-partners-for-stem-cell-trials/story-e6frg90f-1227390242937″>Mesoblast lining up partners for stem cell trials The Australian Mesoblast's 30-patient trial found an injection of the company's MPC-300-IV product, an allogeneic mesenchymal precursor cell, was safe and improved organ function. The Melbourne-based company presented the results in poster form at the annual … Mesoblast eyes pharma deals after diabetes trial success Postive Trial Results Of Mesoblast Cell Therapy In Patients With Diabetes And … |
